USPTO Deadlines
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 24, 2009 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Jul 24, 2009 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Dec 21, 2008 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 21, 2008 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 21, 2008 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 21, 2008 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 26, 2008 | MDSM | O | NOTICE OF DESIGN SEARCH CODE MAILED | Loading... |
| Sep 25, 2008 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Business investigations, evaluations, expert appraisals, information and research; Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare; Promoting technical and scientific investigation, research, and experimentation in the field of advancement of the application of scientific discovery for the betterment of humankind through support of educational institutions and scientific organizations; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of healthcare; Promoting the exchange of information and resources within the scientific research communities to achieve advances in the field of 21st century transformational science
First Use Anywhere:
Apr 18, 2008
First Use in Commerce:
Apr 18, 2008
Class 036
Financing medical research of others
First Use Anywhere:
Apr 18, 2008
First Use in Commerce:
Apr 18, 2008
Class 042
Compiling data for research purposes in the field of medical science and medical consultancy; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Pharmaceutical research and development; Pharmaceutical research services; Research on the subject of pharmaceuticals; Scientific research and development
First Use Anywhere:
0
First Use in Commerce:
0
Class 045
Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of A styalized depiction of the word BioDiligence with "Bio" colored green. A sweeping "D" incorporates a DNA strand as the verticle line, transitioning from green to blue as it sweeps to the right. "BioDiligence" is underlined with a gradually darkening blue line to indicate progression, and the words "Advancing Research to Therapy" are below this line.
Color Claim
The color(s) green blue is/are claimed as a feature of the mark.
Pseudo Mark
BIO DILIGENCE, LLC ADVANCING RESEARCH TO THERAPY
Classification
International Classes
035
036
042
045